CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Organogenesis Holdings Inc. Shareholders of Securities Fraud Class Action Lawsuit | State

RADNOR, Pa., January 20, 2022 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against Organogenesis Holdings Inc. (“Organogenesis”) (NASDAQ: ORGO). The lawsuit alleges that Organogenesis violated federal securities laws, including omissions and fraudulent misrepresentations regarding the company’s business, operations and prospects. As a result of Organogenesis’ materially misleading public statements, investors in Organogenesis have suffered significant losses.

CAN’T WATCH THIS VIDEO? YOU’RE WELCOME CLICK HERE

CLICK HERE TO TRANSMIT YOUR ORGANOGENESIS LOSSES

LIMIT FOR THE PLAINTIFF: February 8, 2022

LESSON: March 17, 2021 through October 11, 2021

CONTACT AN ATTORNEY TO DISCUSS YOUR RIGHTS:

James Maro, Esq. (484) 270-1453 or duty free (844) 887-9500 or email info@ktmc.com

ORGANOGENESIS ALLEGED MISCONDUCT

Organogenesis is a regenerative medicine company that develops, manufactures and markets solutions for the advanced wound care, surgical and sports medicine markets. The Company’s advanced wound care products include Affinity, an amniotic allograft wound dressing and surgical barrier for use in the management of chronic and acute wounds or for surgical implantation in spine, orthopedic and sports medicine applications.

on October 12, 2021, an anonymous report, the VIC Report, dealing with Organogenesis was published in Value Investors Club. The report alleged that Organogenesis improperly billed the federal government $250 million yearly. In addition, the VIC report claimed that Organogenesis priced its new Affinity wound dressing “exorbitantly high.”[,]’ that Medicare reimbursed while making the product lucrative for physicians through large discounts, and that Organogenesis used a similar tactic for its new PuraPly XT product. In addition, the report claimed that “Organogenesis doctors, often unethical podiatrists, covid pain, rebates on Affinity[,]” and the “[t]These rebates could be as high as 30%, and physicians are collecting the difference between the amount reimbursed and what they paid to Organogenesis.” Following the news, Organogenesis’ stock price fell $1.70 per share, or 14.11% to close $10.35 per share October 12, 2021.

WHAT CAN I DO?

organogenesis Investors can not later than February 8, 2022, seek to be appointed as lead counsel for the class action through Kessler Topaz Meltzer & Check, LLP, another counsel, or may elect to do nothing and remain an absent class plaintiff. Kessler Topaz Meltzer & Check, LLP encourages Organogenesis investors who have suffered material losses to contact the company directly for additional information.

CLICK HERE SIGN UP FOR THE EVENT

Who can be a lead plaintiff?

A Lead Plaintiff is a representative party acting on behalf of all Group Members in conducting the litigation. The lead plaintiff is usually the investor or small group of investors who have the greatest financial interest and who are also appropriate and typical of the proposed class of investors. The lead plaintiff selects counsel to represent the lead plaintiff and class, and such attorneys, where permitted by the court, are principal or class counsel. Your ability to participate in a recovery will not be affected by the decision whether or not to serve as Lead Plaintiff.

ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP

Kessler Topaz Meltzer & Check, LLP is pursuing class action lawsuits in state and federal courts across the country and around the world. The company has built an excellent reputation around the world, recovering billions of dollars from victims of fraud and other corporate wrongdoing. All of our work is driven by a common goal: to protect investors, consumers, employees and others from fraud, abuse, wrongdoing and negligence on the part of companies and fiduciaries. At the end of the day, if the bad guys pay and you get your fortune back, we’re done. The action in this lawsuit was not filed by Kessler Topaz Meltzer & Check, LLP. Additional information about Kessler Topaz Meltzer & Check, LLP is available at www.ktmc.com.

CONTACT:

Kessler Topaz Meltzer & Check, LLP

James Maro, Jr., Esq.

280 König-von-Prussia-Strasse

Radnor, PA 19087

(844) 887-9500 (toll free)

info@ktmc.com

View original content to download multimedia: https://www.prnewswire.com/news-releases/class-action-alert–kessler-topaz-meltzer–check-llp-reminds-organogenesis-holdings-inc -shareholders-of-securities-fraud-class-action-301464950.html

SOURCE Kessler Topaz Meltzer & Check, LLP

Comments are closed.